Mochida Pharmaceutical Co., Ltd. (TYO:4534)
3,450.00
+35.00 (1.02%)
May 29, 2026, 3:30 PM JST
Mochida Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 28,064 | 45,154 | 33,290 | 47,010 | 48,415 |
Short-Term Investments | 2,993 | 5,996 | 13,499 | 13,499 | 13,499 |
Cash & Short-Term Investments | 31,057 | 51,150 | 46,789 | 60,509 | 61,914 |
Cash Growth | -39.28% | 9.32% | -22.67% | -2.27% | -2.48% |
Receivables | 36,478 | 31,617 | 34,838 | 27,806 | 31,676 |
Inventory | 36,121 | 33,295 | 30,278 | 24,404 | 23,127 |
Other Current Assets | 15,365 | 3,607 | 4,757 | 4,660 | 4,731 |
Total Current Assets | 119,021 | 119,669 | 116,662 | 117,379 | 121,448 |
Property, Plant & Equipment | 16,302 | 15,940 | 15,874 | 15,049 | 14,528 |
Long-Term Investments | 45,455 | 21,740 | 23,169 | 21,722 | 22,758 |
Other Intangible Assets | 1,121 | 920 | 721 | 797 | 713 |
Long-Term Deferred Tax Assets | 820 | 1,851 | 2,372 | 3,883 | 3,691 |
Other Long-Term Assets | 1 | 1 | 2 | 1 | 1 |
Total Assets | 182,720 | 160,121 | 158,800 | 158,831 | 163,139 |
Accounts Payable | 10,777 | 8,660 | 12,182 | 9,957 | 11,899 |
Accrued Expenses | 2,409 | 2,357 | 2,178 | 2,374 | 2,711 |
Current Income Taxes Payable | 2,970 | 1,510 | 593 | 501 | 1,652 |
Other Current Liabilities | 11,578 | 12,375 | 11,120 | 14,426 | 13,594 |
Total Current Liabilities | 27,734 | 24,902 | 26,073 | 27,258 | 29,856 |
Long-Term Debt | 10,000 | - | - | - | - |
Pension & Post-Retirement Benefits | 3,337 | 3,690 | 3,908 | 4,133 | 4,270 |
Long-Term Deferred Tax Liabilities | 493 | - | - | - | - |
Other Long-Term Liabilities | 831 | 835 | 853 | 666 | 367 |
Total Liabilities | 42,395 | 29,427 | 30,834 | 32,057 | 34,493 |
Common Stock | 7,229 | 7,229 | 7,229 | 7,229 | 7,229 |
Additional Paid-In Capital | 1,871 | 1,871 | 1,871 | 1,871 | 1,871 |
Retained Earnings | 121,251 | 116,114 | 117,022 | 118,943 | 121,668 |
Treasury Stock | -3,270 | -3,267 | -7,021 | -7,114 | -9,617 |
Comprehensive Income & Other | 13,244 | 8,747 | 8,865 | 5,845 | 7,495 |
Shareholders' Equity | 140,325 | 130,694 | 127,966 | 126,774 | 128,646 |
Total Liabilities & Equity | 182,720 | 160,121 | 158,800 | 158,831 | 163,139 |
Total Debt | 10,000 | - | - | - | - |
Net Cash (Debt) | 21,057 | 51,150 | 46,789 | 60,509 | 61,914 |
Net Cash Growth | -58.83% | 9.32% | -22.67% | -2.27% | -2.48% |
Net Cash Per Share | 593.99 | 1442.84 | 1304.66 | 1628.34 | 1624.95 |
Filing Date Shares Outstanding | 35.45 | 35.45 | 35.45 | 36.53 | 37.57 |
Total Common Shares Outstanding | 35.45 | 35.45 | 35.45 | 36.53 | 37.57 |
Working Capital | 91,287 | 94,767 | 90,589 | 90,121 | 91,592 |
Book Value Per Share | 3958.43 | 3686.66 | 3609.61 | 3470.15 | 3424.20 |
Tangible Book Value | 139,204 | 129,774 | 127,245 | 125,977 | 127,933 |
Tangible Book Value Per Share | 3926.80 | 3660.71 | 3589.27 | 3448.33 | 3405.23 |